BioSpace News Archive

Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced the launch of a generic version of Ranexa®1 (ranolazine) Extended-Release Tablets, 500 mg and 1000 mg, in the U.S.

Celgene Corporation (NASDAQ: CELG) today announced the U.S. Food and Drug Administration (FDA) approved REVLIMID® (lenalidomide) in combination with a rituximab product (R²) for the treatment of adult patients with previously treated follicular lymphoma (FL) or marginal zone lymphoma (MZL) following Priority Review designation.

Sensible Medical Innovations and Bayer successfully signed an agreement making Bayer, Sensible’s largest customer in Europe.

Automation of repetitive, rules-based functions will allow healthcare providers to focus more resources on patient needs

IDEAYA Biosciences, Inc. (Nasdaq:IDYA) today announced the closing of its initial public offering of 5,750,000 shares of common stock at a public offering price of $10.00 per share.

Novuson Surgical, a Bothell, WA based medical device company, has secured funding from HOYA Corporation to finalize development for the UltraStat 3mm Vessel Sealer / Divider using Direct Therapeutic Ultrasound (DTU)

The CEO and Co-Founder of Surgical Theater, Moty Avisar, will share the value of Precision VR® at the Hong Kong Exchanges and Clearing (HKEX) Biotech Week.

Physicians’ Education Resource® (PER®), a worldwide leading resource for continuing medical education (CME), will present its ASCO Direct™ Highlights Saturday, June 29, at the Millennium Maxwell House Nashville in Tennessee

Results are 1,565% sales growth over Q1 2018, Gain on Non-Operating Income overcomes high COGS to produce Net Income for the Quarter of $986,000

Xylyx Bio, a pioneer in physiomimetic cell culture, today announced that it is expanding globally to meet growing international demand for its physiologic cell culture products